merged_adhd-life-expectancy.txt
<question_number>1</question_number>
<answer>The JAMA meta-analysis reported cause-specific (unnatural-cause) mortality (2.81×), while the British study used all-cause mortality to estimate reduced life expectancy—different endpoints not directly comparable.</answer>
<question_number>2</question_number>
<answer>Because the British study did not record causes of death, one cannot know which causes drove excess mortality (e.g., suicide vs disease), so targeting only identified comorbidities might miss the actual drivers.</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<question_number>4</question_number>
<answer>The study noted A.D.H.D. is substantially underdiagnosed and that its sample were mostly diagnosed as young adults (possibly more severe), yet diagnoses have surged among older people—especially women and people of color—implying the study sample may not represent the broader, newly diagnosed population.</answer>
<question_number>5</question_number>
<answer>N/A</answer>